Quick Answer
IMMUNIC, INC. reported Operating Income of -$103.23 million for fiscal year 2025.
IMMUNIC, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$103.23M | -5.3% |
| 2024 | -$98.05M | +1.2% |
| 2023 | -$99.22M | +17.0% |
| 2022 | -$119.49M | -30.4% |
| 2021 | -$91.67M | -87.2% |
| 2020 | -$48.97M | -32.2% |
| 2019 | -$37.03M | -208.7% |
| 2018 | -$12.00M | +77.2% |
| 2017 | -$52.66M | -27.6% |
| 2016 | -$41.27M | +20.8% |
| 2015 | -$52.12M | -3.5% |
| 2014 | -$50.34M | -60.3% |
| 2013 | -$31.40M | -227.8% |
| 2012 | -$9.58M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$25.99M | -1.0% | +4.0% |
| June 30, 2025 | -$27.08M | -18.7% | -1.0% |
| March 31, 2025 | -$26.82M | -12.3% | -4.3% |
| September 30, 2024 | -$25.73M | -9.1% | -12.8% |
| June 30, 2024 | -$22.81M | +8.8% | +4.5% |
| March 31, 2024 | -$23.88M | +12.4% | -1.3% |
| September 30, 2023 | -$23.57M | -17.2% | +5.8% |
| June 30, 2023 | -$25.02M | -21.4% | +8.2% |
- IMMUNIC, INC. showed a decrease of -5.3% in Operating Income compared to the prior fiscal year.
- Over the 2012–2025 period, IMMUNIC, INC.’s operating income has declined by 977.5% (from -$9.58 million to -$103.23 million).
- The most recent figure is from IMMUNIC, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: